53 results
DEFA14A
EX-4.1
FWBI
First Wave BioPharma Inc
14 Mar 24
Additional proxy soliciting materials
6:10am
8-K
EX-4.1
FWBI
First Wave BioPharma Inc
14 Mar 24
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease
6:09am
8-K
EX-4.2
FWBI
First Wave BioPharma Inc
5 Mar 24
First Wave BioPharma, Inc. to raise approximately $4.0 million of Gross Proceeds in Registered Direct Offering
5:26pm
8-K
EX-4.1
FWBI
First Wave BioPharma Inc
5 Mar 24
First Wave BioPharma, Inc. to raise approximately $4.0 million of Gross Proceeds in Registered Direct Offering
5:26pm
8-K
EX-4.1
FWBI
First Wave BioPharma Inc
27 Dec 23
First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced
5:23pm
8-K
EX-4.1
4jkubrw9i
15 Sep 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-4.1
v0f26u9umb
21 Jul 23
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering
8:19am
8-K
EX-4.2
v9rwg1o
21 Jul 23
First Wave BioPharma, Inc. Announces Pricing of $2.1 Million Public Offering
8:19am
8-K
EX-4.1
qgf0zzox1exzj91fh
16 Jun 23
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-4.2
46gr64hxb pezfaosg
15 Mar 23
First Wave BioPharma Announces $4.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
11:13am
8-K
EX-4.1
uum9vdjni vd3sdv
15 Mar 23
First Wave BioPharma Announces $4.0 Million Private Placement Priced At-The-Market under Nasdaq Rules
11:13am
8-K
EX-4.1
xersr6w gxy8bw4
22 Nov 22
First Wave BioPharma, Inc. Announces Private Placement
8:00am
8-K
EX-4.3
ijv8z 5h7l9c3539rmew
22 Nov 22
First Wave BioPharma, Inc. Announces Private Placement
8:00am